Overview
Chronic osteomyelitis of the femur with a draining sinus is a persistent bone infection characterized by ongoing inflammation, bone destruction, and the presence of a chronic wound tract that drains pus or serous fluid. This condition significantly impacts patient quality of life due to pain, functional impairment, and recurrent infections. It commonly affects individuals with a history of trauma, previous orthopedic surgeries, or underlying conditions that compromise immune function. Early and effective management is crucial to prevent further bone loss, joint destruction, and systemic complications. In day-to-day practice, accurate diagnosis and timely intervention are essential to optimize outcomes and reduce the risk of chronic disability 1.Pathophysiology
Chronic osteomyelitis arises from an unresolved acute infection, often involving bacteria such as Staphylococcus aureus or Pseudomonas aeruginosa. The initial infection triggers an inflammatory response, leading to bone necrosis and the formation of a necrotic bone core, or sequestrum. Over time, this process evolves into a chronic state characterized by persistent inflammation, granulation tissue formation, and the establishment of biofilms on the infected bone surfaces. These biofilms protect microorganisms from antibiotics and host defenses, perpetuating the infection 1.The presence of a draining sinus indicates ongoing infection and communication between the bone and the external environment. This communication facilitates continuous bacterial shedding and complicates eradication of the infection. Additionally, mechanical stress and microtrauma at the sinus site can exacerbate inflammation and hinder healing. Molecularly, the chronic phase involves complex interactions between immune cells, cytokines (such as TNF-α and IL-6), and growth factors, which contribute to the persistent inflammatory state and impaired bone healing 1.
Epidemiology
The incidence of chronic osteomyelitis varies but is notably higher in populations with predisposing factors such as diabetes, peripheral vascular disease, and a history of trauma or surgical interventions. Specific prevalence figures are not universally reported, but studies suggest that chronic osteomyelitis affects approximately 5-10% of patients with post-traumatic or post-surgical infections 1. Age and sex distribution often show no significant gender predilection, though older adults and those with compromised immune systems are at higher risk. Geographic factors can influence incidence due to differences in healthcare access and infection control practices. Trends over time indicate an increasing prevalence linked to aging populations and improved diagnostic capabilities 1.Clinical Presentation
Patients with chronic osteomyelitis of the femur often present with persistent pain localized to the affected area, swelling, and signs of systemic infection such as fever and malaise. A hallmark feature is the presence of a draining sinus tract, which may discharge purulent material or serous fluid. Other symptoms include limited range of motion, functional impairment, and in severe cases, deformity of the limb. Red-flag features include rapid progression of symptoms, systemic signs of sepsis (e.g., hypotension, tachycardia), and failure to respond to initial antibiotic therapy, necessitating prompt referral for definitive management 1.Diagnosis
The diagnostic approach for chronic osteomyelitis involves a combination of clinical assessment, imaging, and laboratory tests. Key steps include:Specific Criteria and Tests:
Management
Initial Management
Surgical Intervention
Refractory Cases
Complications
Prognosis & Follow-Up
The prognosis for chronic osteomyelitis varies based on the extent of bone destruction, response to initial treatment, and presence of comorbidities. Positive prognostic indicators include early diagnosis, appropriate antibiotic therapy, and successful surgical intervention. Regular follow-up intervals typically include:Special Populations
Key Recommendations
References
1 Chen Z, Xing Y, Li X, Liu B, Liu N, Huo Y et al.. 3D-printed titanium porous prosthesis combined with the Masquelet technique for the management of large femoral bone defect caused by osteomyelitis. BMC musculoskeletal disorders 2024. link 2 Fyda TM, Callaghan JJ, Olejniczak J, Johnston RC. Minimum ten-year follow-up of cemented total hip replacement in patients with osteonecrosis of the femoral head. The Iowa orthopaedic journal 2002. link 3 Loha T, Pal B. Effect of Design Parameters of an Uncemented Hip Stem on Bone Ingrowth-Finite Element Analyses Integrated With Mechanoregulatory Algorithm and Design of Experiment. Journal of biomedical materials research. Part B, Applied biomaterials 2025. link 4 Sautet P, Parratte S, Mékidèche T, Abdel MP, Flécher X, Argenson JN et al.. Antibiotic-loaded tantalum may serve as an antimicrobial delivery agent. The bone & joint journal 2019. link 5 Kelly EG, Cashman JP, Imran FH, Conroy R, O'Byrne J. Systematic review and meta-analysis of closed suction drainage versus non-drainage in primary hip arthroplasty. Surgical technology international 2014. link 6 Conroy MJ, Pédrono A, Bechtold JE, Søballe K, Ambard D, Swider P. High-resolution magnetic resonance flow imaging in a model of porous bone-implant interface. Magnetic resonance imaging 2006. link 7 Mehrotra M, Saegusa M, Wadhwa S, Voznesensky O, Peterson D, Pilbeam C. Fluid flow induces Rankl expression in primary murine calvarial osteoblasts. Journal of cellular biochemistry 2006. link 8 Ulmar B, Aschoff AJ, Orend KH, Puhl W, Huch K. Minimally invasive intervention for acute bleeding from a pseudoaneurysm after revision hip arthroplasty. Acta orthopaedica Belgica 2004. link 9 Hofmann S, Hopf R, Mayr G, Schlag G, Salzer M. In vivo femoral intramedullary pressure during uncemented hip arthroplasty. Clinical orthopaedics and related research 1999. link